MXPA03002253A - Metodo para la produccion de compuestos quirales. - Google Patents

Metodo para la produccion de compuestos quirales.

Info

Publication number
MXPA03002253A
MXPA03002253A MXPA03002253A MXPA03002253A MXPA03002253A MX PA03002253 A MXPA03002253 A MX PA03002253A MX PA03002253 A MXPA03002253 A MX PA03002253A MX PA03002253 A MXPA03002253 A MX PA03002253A MX PA03002253 A MXPA03002253 A MX PA03002253A
Authority
MX
Mexico
Prior art keywords
chiral compounds
producing chiral
compound
pharmaceutical compositions
producing
Prior art date
Application number
MXPA03002253A
Other languages
English (en)
Inventor
Matthias Gerlach
Original Assignee
Gr Nenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gr Nenthal Gmbh filed Critical Gr Nenthal Gmbh
Publication of MXPA03002253A publication Critical patent/MXPA03002253A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/18Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by addition of thiols to unsaturated compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/16Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by addition of hydrogen sulfide or its salts to unsaturated compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MXPA03002253A 2000-09-14 2001-09-14 Metodo para la produccion de compuestos quirales. MXPA03002253A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10045832A DE10045832A1 (de) 2000-09-14 2000-09-14 Verfahren zur Herstellung chiraler Verbindungen
PCT/EP2001/010626 WO2002022569A1 (de) 2000-09-14 2001-09-14 Verfahren zur herstellung chiraler verbindungen

Publications (1)

Publication Number Publication Date
MXPA03002253A true MXPA03002253A (es) 2003-06-24

Family

ID=7656434

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03002253A MXPA03002253A (es) 2000-09-14 2001-09-14 Metodo para la produccion de compuestos quirales.

Country Status (25)

Country Link
US (1) US20030236429A1 (es)
EP (1) EP1317427B1 (es)
JP (1) JP2004509102A (es)
KR (1) KR20030039371A (es)
CN (1) CN1474808A (es)
AT (1) ATE284867T1 (es)
AU (1) AU2002212241A1 (es)
BR (1) BR0113944A (es)
CA (1) CA2422024A1 (es)
CZ (1) CZ2003733A3 (es)
DE (2) DE10045832A1 (es)
EC (1) ECSP034515A (es)
ES (1) ES2234908T3 (es)
HK (1) HK1052923B (es)
HU (1) HUP0302903A3 (es)
IL (1) IL154915A0 (es)
MX (1) MXPA03002253A (es)
NO (1) NO20031137L (es)
NZ (1) NZ524973A (es)
PL (1) PL363012A1 (es)
PT (1) PT1317427E (es)
RU (1) RU2003109607A (es)
SK (1) SK2792003A3 (es)
WO (1) WO2002022569A1 (es)
ZA (1) ZA200302824B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101643383B (zh) * 2008-12-19 2012-05-23 烟台金正精细化工有限公司 一种1,1-二苯基乙烷绝缘油的制备方法
JP2012136466A (ja) * 2010-12-27 2012-07-19 Sumitomo Chemical Co Ltd 2−オキソ−4−メチルチオブタン酸又はその塩の製造方法
CN105294519B (zh) * 2015-11-20 2017-03-29 哈尔滨工业大学(威海) 一种海洋天然产物apratoxin E的moCys片段的合成方法
CN111423332B (zh) * 2020-05-25 2023-02-10 上海科技大学 一种拆分手性化合物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2217706A (en) * 1988-07-07 1989-11-01 W A Gibbons alpha -Amino-alkanoic acid derivatives and process for their preparation with anti-inflammatory, analgesic, sedative, hypnotic, anxiolytic, spasmolytic, anaesthetic, muscle relaxant and cardiovascular activity

Also Published As

Publication number Publication date
IL154915A0 (en) 2003-10-31
CN1474808A (zh) 2004-02-11
SK2792003A3 (en) 2003-10-07
HUP0302903A3 (en) 2007-05-02
PL363012A1 (en) 2004-11-15
HK1052923B (zh) 2005-06-30
NZ524973A (en) 2005-08-26
WO2002022569A8 (de) 2002-06-13
CA2422024A1 (en) 2003-03-12
ECSP034515A (es) 2003-04-25
WO2002022569A1 (de) 2002-03-21
DE50104847D1 (de) 2005-01-20
RU2003109607A (ru) 2004-10-20
US20030236429A1 (en) 2003-12-25
PT1317427E (pt) 2005-04-29
AU2002212241A1 (en) 2002-03-26
CZ2003733A3 (cs) 2003-09-17
NO20031137D0 (no) 2003-03-12
BR0113944A (pt) 2004-06-22
DE10045832A1 (de) 2002-05-29
HK1052923A1 (en) 2003-10-03
ES2234908T3 (es) 2005-07-01
NO20031137L (no) 2003-05-05
KR20030039371A (ko) 2003-05-17
ATE284867T1 (de) 2005-01-15
ZA200302824B (en) 2004-05-11
EP1317427B1 (de) 2004-12-15
HUP0302903A2 (hu) 2003-12-29
EP1317427A1 (de) 2003-06-11
JP2004509102A (ja) 2004-03-25

Similar Documents

Publication Publication Date Title
WO2001078711A3 (en) Pde-v inhibitors for treatment of parkinson's disease
NZ337861A (en) N-heterocyclic derivatives for treating multiple sclerosis, HIV dementia, Parkinson's disease, meningitis, atherosclerosis, cancer, inflammatory skin diseases
PL345215A1 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
TW200510317A (en) Caspase inhibitors and uses thereof
MY136269A (en) Novel diphenylazetidinone, process for its preparation, medicaments comprising this compound and their use
YU89402A (sh) 5-hloro-3-(4-metansulfonilfenil)-6'-metil-/2,3'/bipiridinil u čistom kristalnom obliku i postupak sinteze
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
GB9712966D0 (en) Novel chalcones
UA66792C2 (uk) Спосіб отримання 2-арил-3-арил-5-галогенпіридинів, що використовуються як інгібітори сох-2 (варіанти)
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
HK1052923A1 (en) Method for producing chiral compounds.
AU2002246317A1 (en) Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof
MXPA04005151A (es) Compuestos terapeuticos.
EP1253139A3 (en) Multioligoanilinated fullerenes
ATE267832T1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
GB0019008D0 (en) Therapeutic compounds
AU2001244999A1 (en) Naphthamide neurokinin antagonists for use as medicaments
MXPA03010737A (es) Aril-8-azabiciclo(3.2.1) octanos para tratamiento de depresion.
AU2368802A (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
CA2301590A1 (en) 2-aminopyridines as inhibitors of cyclooxygenase-2
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
PL353291A1 (en) Novel compounds, method of obtaining them, their application as pigments and composition containing them
MXPA04004537A (es) Derivados de gabusectina, metodo para produccion de los mismos y uso de los mismos.
RO116896B1 (ro) Derivaţi pseudocarbaciclinici şi procedeu pentru prepararea acestora
PL347584A1 (en) Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors